Sensyne Health PLC
LSE:SENS
Sensyne Health PLC
LSE:SENS
Price:
0.35
GBX
-33.33%
Market Closed
Market Cap:
£582.6k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Sensyne Health PLC
LSE:SENS
|
UK |
|
V
|
Viet Thang Corp
VN:TVT
|
VN |
|
Vitrolife AB
STO:VITR
|
SE |
|
Antigenics Inc
OTC:ANTI
|
US |
|
Gaxos.AI Inc
NASDAQ:GXAI
|
US |
|
X
|
Xebra Brands Ltd
CNSX:XBRA
|
CA |
|
V
|
Vikas Lifecare Ltd
BSE:542655
|
IN |
|
Bridgestone Corp
TSE:5108
|
JP |
|
T
|
Tien Len Steel Corporation JSC
VN:TLH
|
VN |
|
P
|
Pangenomic Health Inc
CNSX:NARA
|
CA |
Income Statement
Earnings Waterfall
Sensyne Health PLC
Sensyne Health PLC
Income Statement
Sensyne Health PLC
Sensyne Health PLC
Currency: GBP
| Apr-2019 | Oct-2019 | Apr-2020 | Oct-2020 | Apr-2021 | Oct-2021 | ||
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue |
0
N/A
|
0
+260%
|
2
+320%
|
4
+94%
|
9
+129%
|
8
-14%
|
|
| Gross Profit | |||||||
| Cost of Revenue |
(0)
|
(0)
|
(1)
|
(2)
|
(3)
|
(3)
|
|
| Gross Profit |
(0)
N/A
|
0
N/A
|
1
+332%
|
2
+94%
|
6
+163%
|
5
-15%
|
|
| Operating Income | |||||||
| Operating Expenses |
(16)
|
(18)
|
(22)
|
(26)
|
(33)
|
(40)
|
|
| Selling, General & Administrative |
(7)
|
(8)
|
(11)
|
(13)
|
(17)
|
(21)
|
|
| Research & Development |
(8)
|
(10)
|
(11)
|
(13)
|
(16)
|
(19)
|
|
| Operating Income |
(16)
N/A
|
(18)
-14%
|
(21)
-18%
|
(24)
-13%
|
(27)
-13%
|
(35)
-32%
|
|
| Pre-Tax Income | |||||||
| Interest Income Expense |
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
|
| Non-Reccuring Items |
(3)
|
(1)
|
(1)
|
(2)
|
(1)
|
0
|
|
| Total Other Income |
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(19)
N/A
|
(19)
+2%
|
(23)
-22%
|
(27)
-17%
|
(28)
-7%
|
(36)
-26%
|
|
| Net Income | |||||||
| Tax Provision |
0
|
0
|
1
|
0
|
1
|
0
|
|
| Income from Continuing Operations |
(19)
|
(19)
|
(22)
|
(26)
|
(28)
|
(35)
|
|
| Net Income (Common) |
(22)
N/A
|
(19)
+16%
|
(22)
-18%
|
(26)
-18%
|
(28)
-7%
|
(35)
-27%
|
|
| EPS (Diluted) |
-0.17
N/A
|
-0.14
+18%
|
-0.17
-21%
|
-0.2
-18%
|
-0.18
+10%
|
-0.21
-17%
|
|
Switch to:
Switch to:
See Also
Discover More
